Argelia Medeiros Domingo MD, PhD
Medical Director and Founder
Dr. Argelia Medeiros is a Cardiolgist, Electrophysiologist with more than 12 years experience in the field of Cardiogenetics. She got her Medical and Cardiology title in Mexico City by the National University of Mexico and National Institute of Cardiac diseases. She performed additional cardiac electrophysiology traing at the Academic Hospital of Maastricht. During her PhD in Biomedical Sciences (Molecular Genetics) she joined the Sudden Cardiac Death laboratory at Mayo Clinic for 7 years. She led the Cardiogenetic consultation at the University Hospital of Bern for 5 years. She has been part of several research projects on inherited cardiac diseases, genotype-phenotype correlations, functional studies of novel genes and gene-mutations and population-genetic studies. In 2018 she founded Swiss DNAlysis.
Franziska Joncourt PhD, Genetic Analyst FAMH
Advisor and Deputy Head of Laboratory
Dr. Franziska Joncourt studied biology at the University of Bern. After completing her studies, she worked for 15 years on various research projects at 3 different university institutions. At the end of 1996, she moved to the Department of Human Genetics at the University Hospital Bern, where she obtained the title of Specialist in Medical Genetic Analysis (FAMH) in 2004. There she was responsible for the quality control of the molecular genetics laboratory until the end of 2018. With a long trajectory of 21 years working in human genetics, Dr. Joncourt has deep knowledge in quality control, accreditation processes, excellent command of the main laboratory techniques for genetic studies and since September 2019 she directs the laboratory in SwissDNAlysis.
Christoph Peter Bagowski PhD
Dr. Christoph Bagowski is a human geneticist with more than 10 years of experience in human genetic diagnostics. He studied biochemistry at the Free University of Berlin, received his PhD in molecular genetics at the Max Planck Institute in Martinsried near Munich, and spent three years as a postdoc at Stanford University in basic research. After two more years in California as a senior scientist in a biotech company, he accepted an appointment at the University of Leiden in the Netherlands, where he spent five years as an assistant professor leading a group in cancer research. He then continued his research as a professor at the German University in Cairo and as a visiting professor at the University of Greifswald. In the following 10 years, he headed molecular genetics departments in Rostock and Munich, gaining extensive experience in human genetics and related molecular genetic methods, especially high-throughput sequencing (NGS). He also gained extensive knowledge in laboratory management and quality assurance. Since May 2021, he has been contributing his experience and knowledge as laboratory manager at Swiss DNAlysis.
Nina A. Schlipf, PhD
Novel Test and Innovation Development
Dr. Nina Schlipf studied biology at the University of Tübingen (Germany) with focus on human genetics. She carried out her diploma thesis at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen (Germany), where she also accomplished her PhD. During her PhD-thesis, she applied high-throughput genetic analyses, including next-generation sequencing, for mutation screening and candidate gene identification of hereditary spastic paraplegias. Afterwards, she was a staff member of the Institute of Human Genetics at the University Hospital Freiburg (Germany), where she gained broad knowledge in genetic diagnostics. Her research activities were focused on genetics of neurodegenerative diseases and genodermatoses. She joined Swiss DNAlysis team in 2019.
Jiunshan Jung, MSc
Jiunshan Jung studied molecular biology at the Graduate Institute of Basic Medical Science at the University of Chang-Gung (Taipei, Taiwan) with focusing on gene therapy and vaccine development. During her Master’s studies she examined the nucleotide sequence difference of several virus strains. After completing her master’s degree she continued doing research at the Virology Research Center at the University of Chang-Gung working in the construction of viral gene plasmids as DNA vaccines. Afterwards, she worked in the institute of medical virology at the University of Zürich in Switzerland, where she gained extensive knowledge in gene therapy and cell engineering using viral vectors. Later, she worked at the Zurich Children’s Hospital at the metabolic laboratory with patient-samples for DNA sequencing.
In June 2021 she joined Swiss DNAlysis as expert technician.
Cecilia-Conte Grand PhD
Dr. Cecilia Conte-Grand obtained her bachelor’s degree in Biology in 2005 by “Universidad Nacional del Sur”, Argentina. She finished a doctorate degree in 2012 at the same university. In Switzerland she worked at the Naturhistorisches Museum der Burgergemeinde (NMBE, Bern, Switzerland) with a DNA barcoding project, leading the genetics lab work. Later she studied the genetic growth control in Drosophila at the Center for Integrative Genomics (UNIL, Lausanne, Switzerland). During 2021 and 2022, she participated in the Coronavirus testing campaign at the Triemli Zurich hospital. Since October 2022 she joined the Swiss DNAlysis team es expert technician.